Smart Implantable Pumps Market Research Report by Type (Micro Pumps and Perfusion Pumps), Application, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027

Description

List of Tables

The Global Smart Implantable Pumps Market size was estimated at USD 1,295.25 million in 2021 and expected to reach USD 1,436.65 million in 2022, and is projected to grow at a CAGR 11.09% to reach USD 2,434.98 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Smart Implantable Pumps to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the market was studied across Micro Pumps and Perfusion Pumps.

Based on Application, the market was studied across Cardiovascular and Pain & Spasticity.

Based on End User, the market was studied across Ambulatory Surgical Centers and Hospitals.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Smart Implantable Pumps market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Smart Implantable Pumps Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Smart Implantable Pumps Market, including Abbott Laboratories, Absolute Medical Services, Inc, Baxter International, Becton Dickinson (BD), Berlin Heart Inc, Bioptechs, Chemyx Inc, Cognos Therapeutics, Inc., Flowonix Medical Inc, Fresenius Kabi, Intarcia Therapeutics, Inc., Ivenix, Inc., Levitronix, Medtronic, plc., Micrel Medical Devices, Q Core Medical Ltd, and Tricumed Medizintechnik GmbH.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Smart Implantable Pumps Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Smart Implantable Pumps Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Smart Implantable Pumps Market?
4. What is the competitive strategic window for opportunities in the Global Smart Implantable Pumps Market?
5. What are the technology trends and regulatory frameworks in the Global Smart Implantable Pumps Market?
6. What is the market share of the leading vendors in the Global Smart Implantable Pumps Market?
7. What modes and strategic moves are considered suitable for entering the Global Smart Implantable Pumps Market?

Product Code: MRR-0375F3EA9C4C

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising prevalence of chronic diseases such as hypertension, spasticity & heart failures
  - 5.1.1.2. Demand to reduce adverse drug event rates
  - 5.1.1.3. Rising adoption due to significant advantages over manual administration of fluids and ability to deliver fluids precisely
- 5.1.2. Restraints
  - 5.1.2.1. Product recall notifications
- 5.1.3. Opportunities
  - 5.1.3.1. Rising healthcare expenditure and improving services
  - 5.1.3.2. Collaborative development by industry players for product improvement
- 5.1.4. Challenges
  - 5.1.4.1. Growing rental business for smart implantable pumps
5.2. Cumulative Impact of COVID-19

6. Smart Implantable Pumps Market, by Type

6.1. Introduction
6.2. Micro Pumps
6.3. Perfusion Pumps

7. Smart Implantable Pumps Market, by Application

7.1. Introduction
7.2. Cardiovascular
7.3. Pain & Spasticity

8. Smart Implantable Pumps Market, by End User

8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals

9. Americas Smart Implantable Pumps Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Smart Implantable Pumps Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand

11. Europe, Middle East & Africa Smart Implantable Pumps Market

11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
- 12.1.1. Quadrants
- 12.1.2. Business Strategy
- 12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
- 12.4.1. Merger & Acquisition
- 12.4.2. Agreement, Collaboration, & Partnership
- 12.4.3. New Product Launch & Enhancement
- 12.4.4. Investment & Funding
- 12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles

13.1. Abbott Laboratories
13.2. Absolute Medical Services, Inc
13.3. Baxter International
13.4. Becton Dickinson (BD)
13.5. Berlin Heart Inc
13.6. Bioptechs
13.7. Chemyx Inc
13.8. Cognos Therapeutics, Inc.
13.9. Flowonix Medical Inc
13.10. Fresenius Kabi
13.11. Intarcia Therapeutics, Inc.
13.12. Ivenix, Inc.
13.13. Levitronix
13.14. Medtronic, plc.
13.15. Micrel Medical Devices
13.16. Q Core Medical Ltd
13.17. Tricumed Medizintechnik GmbH

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing